| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 741459 | (11aS)-8-(3-[(11aS)-2,2-difluoro-7-methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl]oxypropoxy)-2,2-difluoro-7-methoxy-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4 | 0.0352028253287042 | 0.062116601 |
| NSC 751042 | Null | 0.0352028253287042 | 0.058224725 |
| NSC 751605 | (E)-N-[4-(1-benzoylpiperidine-4-yl)butyl]-3-(pyridin-3-yl)acrylamide | 0.0352028253287042 | 0.27641851 |
| NSC 752761 | Null | 0.0352028253287042 | 0.015091508 |
| NSC 753598 | Null | 0.0352028253287042 | 0.32766661 |
| NSC 81280 | Null | 0.0352028253287042 | -0.058395229 |
| NSC 619042 | Cyclohexanone, 2,6-bis[(dimethylamino)methyl]-, dihydrochloride | 0.0361455178924429 | 0.1208675 |
| NSC 661939 | Null | 0.0361455178924429 | 0.14329992 |
| NSC 669145 | 2-Butenoic acid, 2-methyl-, 2,3,3a,4,5,6,7,11a-octahydro- 6,10-dimethyl-3-methylene-2,7-dioxo-6,9-epoxycyclodeca[b]furan-4-yl ester, [3aR-[3aR*,4S*(Z),6R*,10Z,11aR*]]- | 0.0361455178924429 | 0.33291886 |
| NSC 675223 | 1H-1,2,4-Triazole-5(4H)-one, 4-[[(4-nitrophenyl)methylene] amino]-3-phenyl- | 0.0361455178924429 | -0.20099892 |